179 related articles for article (PubMed ID: 30458366)
1. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
Kawahara B; Ramadoss S; Chaudhuri G; Janzen C; Sen S; Mascharak PK
J Inorg Biochem; 2019 Feb; 191():29-39. PubMed ID: 30458366
[TBL] [Abstract][Full Text] [Related]
2. Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome.
Surowiak P; Materna V; Maciejczyk A; Pudełko M; Markwitz E; Spaczyński M; Dietel M; Zabel M; Lage H
Virchows Arch; 2007 Mar; 450(3):279-85. PubMed ID: 17235562
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity.
Kawahara B; Moller T; Hu-Moore K; Carrington S; Faull KF; Sen S; Mascharak PK
J Med Chem; 2017 Oct; 60(19):8000-8010. PubMed ID: 28876927
[TBL] [Abstract][Full Text] [Related]
4. Reaction of carbon monoxide with cystathionine β-synthase: implications on drug efficacies in cancer chemotherapy.
Kawahara B; Sen S; Mascharak PK
Future Med Chem; 2020 Feb; 12(4):325-337. PubMed ID: 32031001
[TBL] [Abstract][Full Text] [Related]
5. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
Bhattacharyya S; Saha S; Giri K; Lanza IR; Nair KS; Jennings NB; Rodriguez-Aguayo C; Lopez-Berestein G; Basal E; Weaver AL; Visscher DW; Cliby W; Sood AK; Bhattacharya R; Mukherjee P
PLoS One; 2013; 8(11):e79167. PubMed ID: 24236104
[TBL] [Abstract][Full Text] [Related]
6. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
[TBL] [Abstract][Full Text] [Related]
7. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
Masters JR; Thomas R; Hall AG; Hogarth L; Matheson EC; Cattan AR; Lohrer H
Eur J Cancer; 1996 Jun; 32A(7):1248-53. PubMed ID: 8758261
[TBL] [Abstract][Full Text] [Related]
9. Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells.
Abe T; Gotoh S; Higashi K
Biochem Pharmacol; 1999 Jul; 58(1):69-76. PubMed ID: 10403520
[TBL] [Abstract][Full Text] [Related]
10. Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin.
Nikounezhad N; Nakhjavani M; Shirazi FH
J Exp Ther Oncol; 2017 May; 12(1):1-7. PubMed ID: 28472558
[TBL] [Abstract][Full Text] [Related]
11. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells.
Sarkhosh-Inanlou R; Molaparast M; Mohammadzadeh A; Shafiei-Irannejad V
Chem Biol Drug Des; 2020 Feb; 95(2):215-223. PubMed ID: 31512406
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex.
Lee JH; Chae JW; Kim JK; Kim HJ; Chung JY; Kim YH
J Control Release; 2015 Oct; 215():82-90. PubMed ID: 26210439
[TBL] [Abstract][Full Text] [Related]
15. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Mistry P; Loh SY; Kelland LR; Harrap KR
Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
[TBL] [Abstract][Full Text] [Related]
16. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
Perego P; Gatti L; Righetti SC; Beretta GL; Carenini N; Corna E; Dal Bo L; Tinelli S; Colangelo D; Leone R; Apostoli P; Lombardi L; Beggiolin G; Piazzoni L; Zunino F
Int J Cancer; 2003 Jul; 105(5):617-24. PubMed ID: 12740909
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
18. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.
Surowiak P; Materna V; Kaplenko I; Spaczyński M; Dietel M; Lage H; Zabel M
Virchows Arch; 2005 Sep; 447(3):626-33. PubMed ID: 15968547
[TBL] [Abstract][Full Text] [Related]
19. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.
Schilder RJ; Hall L; Monks A; Handel LM; Fornace AJ; Ozols RF; Fojo AT; Hamilton TC
Int J Cancer; 1990 Mar; 45(3):416-22. PubMed ID: 2307530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]